
    
      This research project is designed to give lipid emulsion enriched with omega-3 fish oil to
      conscious adult patients with mental capacity to consent for themselves and with severe acute
      pancreatitis in Leicester General Hospital wards or units.

      Potential participants with SAP will be identified by the patient's own team and referred to
      the researchers for consideration and eventual enrolling in the study. Unconscious patients
      or unable to consent for themselves will be EXCLUDED from the study.

      Randomization:

      Patients will be randomised to receive Lipidem 200 mg/ml OR Lipofundin MCT/LCT 20% lipid
      emulsion from random number tables. Randomization, blinding procedure (over labeling) will be
      conducted by an independent licensed pharmaceutical unit.
    
  